Childhood trauma linked to heart risk: can a supplement help?

NCT ID NCT07244809

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether early life adversity (like abuse or neglect) damages blood vessel function in young adults ages 18-29. Researchers will give participants a single dose of MitoQ, a supplement that targets cell energy centers, to see if it reduces stress-related damage. The goal is to understand the biological link between childhood stress and future heart disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Mitoquinone mesylate (MitoQ) dietary supplement

What this could lead to

If successful, this could point toward a way to reduce cardiovascular risk in people who experienced childhood adversity.

What could go wrong

This is an early pilot study with a single dose of supplement, so results may not translate to long-term benefits or apply to everyone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OXIDATIVE STRESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Integrative Laboratory of Applied Physiology and Lifestyle Medicine

    RECRUITING

    Iowa City, Iowa, 52242, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••